1McGowan KM, Long SD, Pekala PH (1995) Glucose transporter gene expression: Regulation of transcription and mRNA stability. Pharmacology & Therapeutics 66:465-505.
2Wahl RL (1996) Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. J NuclMed 37: 1038-1041.
3Nakanishi T, Tamai I (2011). Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy. J Pharm Sci 100: 3731-3750.
4Okudaira H, Shikano N, Nishii R, Miyagi T, Yoshimoto M, Kobayashi M, et al. (2011) Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer. J NuclMed 52 :822-829.
5Fan X, Ross DD, Arakawa H, Ganapathy V, Tamai I, et al. (2010) Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: A possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. BiochemPharmacol 80 :811-818.
6Nakanishi T, Tamai I, Sai Y, Sasaki T, Tsuji A (1997) Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080. Cancer Res 57: 4118-4122.
7Nakanishi T, Tamai I, Takaki A, Tsuji A (2000) Cancer cell-targeted drug delivery utilizing oligopeptide transport activity. Int J Cancer 88: 274-280.
8Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, et al. (2008) Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter. J Nucl Med 49: 615-622.
9Okudaira H, Nakanishi T, Oka S, Kobayashi M, Tamagami H, et al. (2013) Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopuslaevis oocytes expressing human ASCT2 and SNAT2. Nucl Med Biol 40: 670-675.
10Hagenbuch B, Meier P (2004) Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. PflugersArch 447: 653-665.
11Nakanishi T, Tamai I (2012) Genetic polymorphisms of OATP transporters and their Impact on intestinal absorption and hepatic disposition of drugs. Drug MetabPharmacokinet 27: 106-121.
12Tamai I, Nezu J-i, Uchino H, Sai Y, Oku A, et al. (2000) Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. BiochemBiophys Res Commun 273: 251-260.
13Abe T, Unno M, Onogawa T, Tokui T, Noriko Kondo T, et al. (2001) LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 120: 1689-1699.
14Smith NF, Acharya MR, Desai N, Figg W, Sparreboom A (2005) Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel. Cancer BiolTher 4: 815-818.
15Yamaguchi H, Kobayashi M, Okada M, Takeuchi T, Unno M et al. (2008) Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes. Cancer Lett 260: 163-169.
16Baker SD, Verweij J, Cusatis GA, Van Schaik RH, Marsh S et al. (2008) Pharmacogenetic pathway analysis of docetaxel elimination. ClinPharmacolTher 85: 155-163.
17Hagenbuch B, Meier PJ (2003) The superfamily of organic anion transporting polypeptides. BiochimBiophysActa 1609: 1-18.
18Hagenbuch B, Gui C (2008) Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38: 778-801.
19Muto M, Onogawa T, Suzuki T, Ishida T, Rikiyama T, et al. (2007) Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci 98: 1570-1576.
20Lee W, Belkhiri A, Lockhart AC, Merchant N, Glaeser H, et al. (2008) Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res 68: 10315-10323.
21Thakkar N, Kim K, Jang ER, Han S, Kim D, et al. (2013) A cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells. Mol Pharm 10: 406-416.
22Nagai M, Furihata T, Matsumoto S, Ishii S, Motohashi S, et al. (2012) Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells. BiochemBiophys Res Commun 418: 818-823.
23Wright JL, Kwon EM, Ostrander EA, Montgomery RB, Lin DW, et al. (2011) Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes. Cancer Epidemiol Biomarkers Prev 20: 619-627.
24Hamada A, Sissung T, Price DK, Danesi R, Chau CH, et al. (2008) Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res 14: 3312-3318.
25Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, et al. (2011) SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J ClinOncol 29: 2565-2573.
26Nozawa T, Suzuki M, Takahashi K, Yabuuchi H, Maeda T, et al. (2004) Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells. J PharmacolExpTher 311: 1032-1037.
27Nozawa T, Suzuki M, Yabuuchi H, Irokawa M, Tsuji A, et al. (2005) Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells. Pharm Res 22: 1634-1641.
28Wlcek K, Svoboda M, Sellner F, Krupitza G, Jaeger W, et al. (2008) Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma. Cancer BiolTher 7: 1450-1455.
29Meyer zuSchwabedissen HE, Tirona RG, Yip CS, Ho RH, Kim RB (2008) Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res 68: 9338-9347.
30Bronger H, Konig J, Kopplow K, Steiner H-H, Ahmadi R, et al. (2005) ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res 65:11419-11428.
31Maeda T, Irokawa M, Arakawa H, Kuraoka E, Nozawa T, et al. (2010) Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer. J Steroid BiochemMolBiol 122: 180-185.
32Al SW, Mokbel R, Salhab M, Jiang W, Reed M, et al. (2006) The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Res 26: 4985-4990.
33Brawer MK (2006) Hormonal therapy for prostate cancer. Rev Urol 8: S35-S47.
34LeCluyse EL, Madan A, Hamilton G, Carroll K, DeHaan R, et al. (2000) Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J BiochemMolToxicol 14: 177-188.
35Taplin M-E, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Eng J Med 332: 1393-1398.
36Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34-45.
37Kullak-Ublick G-A, Fisch T, Oswald M, Hagenbuch B, Meier PJ, et al. (1998) Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain. FEBS Lett 424: 173-176.
38Cui Y, Konig J, Leier I, Buchholz U, Keppler D (2001) Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J BiolChem 276: 9626-9630.
39Labrie F, Bélanger A, Cusan L, Gomez J-L, Candas B (1997) Marked decline in serum concentrations of adrenal C19 sex steroid precursorsand conjugated androgen metabolites during aging. J ClinEndocrinolMetab 82: 2396-2402.
40Reed MJ, Purohit A, Woo LWL, Newman SP, Potter BVL (2005) Steroid sulfatase: Molecular biology, regulation, and inhibition. Endocr Rev 26: 171-202.
41Longcope C (1995) Metabolism of dehydroepiandrosterone. Ann N Y AcadSci 774: 143-148.
42Evaul K, Li R, Papari-Zareei M, Auchus RJ, Sharifi N (2010) 3ß-Hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer. Endocrinology 151: 3514-3520.
43Arakawa H, Nakanishi T, Yanagihara C, Nishimoto T, Wakayama T, et al. (2012) Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: Possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions. BiochemPharmacol 84: 1070-1077.